Opinion|Videos|August 14, 2024
When CML Therapy Shifts: Collaborative Approaches to Treatment Changes
Claire Saxton shares insights on how physicians and caregivers can best assist patients with CML who have switched therapies.
Advertisement
Episodes in this series
This program was made possible with support from Novartis Pharmaceuticals.
Video content above is prompted by the following questions:
- In your experience, how can physicians and caregivers both support patients in navigating a therapy change? Which resources can best help support patients during a treatment transition?
Advertisement
Related to this article
Six years after being diagnosed with B-cell ALL at 21, William Yank opens up about the physical changes of treatment, the emotional weight of constant care and the role hope plays in his survivorship.
After two relapses, CAR T-cell therapy and a stem cell transplant, William Yank is in remission. But infertility, mental health challenges and a changed sense of self followed him into survivorship.
Advertisement
Advertisement
Trending on CURE
1
Hot Flashes From Breast Cancer Treatment May Soon Have an FDA-Approved Fix
2
The 5 Most Impactful Phase 3 Cancer Trial Results From September 2026
3
10 Cancer Treatment Approvals From September 2026 and What They Mean for You
4
Radiation Oncologist Answers Top Questions About Radiation Therapy
5